Investments are being made in a five-year trial of the weight loss drug tirzepatide, with a focus on prioritizing patients who can return to work. Health Secretary Wes Streeting highlighted the economic impact of obesity, stating that it not only affects health but also hinders the economy. This announcement aligns with concerns raised in the Darzi report, commissioned by Streeting, about the economic benefits of getting people back to work sooner. Audun Brendbekken and Anand Bhopal from the Bergen Centre for Ethics and Priority Setting in Health contribute their research and expertise to this discussion.
Source link
Prioritising patients back to work: a small step for NICE, a giant leap for the NHS
